Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Presenter: Nanchao Hong

October 26, 2025

Presentation THT 2024

PADN for PH in Left Heart Disease

Presenter: Greg Lewis

March 06, 2024

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Shelley Wood

March 21, 2023

Presentation THT 2023

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Presenter: Dongming Hou

March 21, 2023

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

News Daily News

Sweeter Steps: Cocoa May Boost Walking Ability in PAD

L.A. McKeown

February 14, 2020

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Todd Neale

September 23, 2018

Presentation TCT 2018

PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension

Presenter: Valentin Fuster, Shao-Liang Chen

September 23, 2018

Presentation TCT 2017

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Presenter: Irene M. Lang, Ehtisham Mahmud, Hang Zhang

November 01, 2017

Manuscript

Assessment and Prognostic Impact of Right Ventricular Function in Patients with Pulmonary Arterial Hypertension Undergoing Pulmonary Artery Denervation: Central Role of Global Right Ventricular Longitudinal Peak Systolic Strain

April 28, 2017

Presentation CIT 2014

Case Study of China-Based Innovation:Pulmonary Arterial Denervation(PADN)

Presenter: Shaoliang Chen

March 20, 2014

News Conference News TCT 2013

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

November 05, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Presentation TCT 2013

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Presenter: Shao Liang Chen

October 28, 2013

News Daily News

Pulmonary Denervation Shows Promise for Resistant Pulmonary Hypertension

Yael L. Maxwell

July 19, 2013

News Daily News

La Denervación Pulmonar es Prometedora contra la Hipertensión Pulmonar Resistente

Yael L. Maxwell

July 19, 2013

News Conference News TCT 2012

Pulmonary Artery Denervation Effective for PAH

October 24, 2012

$PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension$

Presentation TCT 2012

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

Presenter: Shao Liang Chen

October 22, 2012

Advertisement

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

PADN for PH in Left Heart Disease

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Sweeter Steps: Cocoa May Boost Walking Ability in PAD

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Assessment and Prognostic Impact of Right Ventricular Function in Patients with Pulmonary Arterial Hypertension Undergoing Pulmonary Artery Denervation: Central Role of Global Right Ventricular Longitudinal Peak Systolic Strain

Case Study of China-Based Innovation:Pulmonary Arterial Denervation(PADN)

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Pulmonary Denervation Shows Promise for Resistant Pulmonary Hypertension

La Denervación Pulmonar es Prometedora contra la Hipertensión Pulmonar Resistente

Pulmonary Artery Denervation Effective for PAH

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content